(Q55467766)

12 July 2018

title

CDC20, a potential cancer therapeutic target, is negatively regulated by p53. (English)

1 reference

12 July 2018

author name string

Kidokoro T

1

1 reference

12 July 2018

Tanikawa C

2

1 reference

12 July 2018

Furukawa Y

3

1 reference

12 July 2018

Katagiri T

4

1 reference

12 July 2018

Nakamura Y

5

1 reference

12 July 2018

Matsuda K

6

1 reference

12 July 2018

language of work or name

English

0 references

publication date

17 September 2007

1 reference

12 July 2018

published in

Oncogene

1 reference

12 July 2018

volume

27

1 reference

12 July 2018

issue

11

1 reference

12 July 2018

page(s)

1562-1571

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210799

exact match

0 references

cites work

Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Regulation of p53 downstream genes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

A roller coaster ride with the mitotic cyclins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Prediction of sensitivity to STI571 among chronic myeloid leukemia patients by genome-wide cDNA microarray analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Isolation of p53-target genes and their functional analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Adenovirus p53 gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Wild-type p53 binds to the TATA-binding protein and represses transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Meta-analysis of the p53 Mutation Database for Mutant p53 Biological Activity Reveals a Methodologic Bias in Mutation Detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

p53 and its downstream proteins as molecular targets of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

p53RDL1 regulates p53-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

p130/E2F4 binds to and represses the cdc2 promoter in response to p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Target gene specificity of E2F and pocket protein family members in living cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Survivin as a target for new anticancer interventions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210799

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210799

1 reference

12 July 2018

Dimensions Publication ID

1030019484

0 references

1 reference

12 July 2018